TY - JOUR
T1 - Complications of anaesthesia in neuromuscular disorders
AU - Klingler, Werner
AU - Lehmann-Horn, Frank
AU - Jurkat-Rott, Karin
N1 - Funding Information:
We thank the two referees of Neuromuscular Disorders for their very valuable suggestions. This work was supported by the German Research Foundation (DFG) (JU470/1) and the network on Excitation-contraction coupling and calcium signaling in health and disease of the IHP Program funded by the European Community.
PY - 2005/3
Y1 - 2005/3
N2 - The purpose of this review is to alert non-anaesthesiologists to the various complications from which patients with neuromuscular disorders and those susceptible to malignant hyperthermia can suffer during anaesthesia. The patient's outcome correlates with the quality of consultation between anaesthesiologists, surgeons, neurologists and cardiologists. Special precautions must be taken, since many anaesthetics and muscle relaxants can aggravate the clinical features or trigger life-threatening reactions. Complications frequently occur in these patients, although anaesthetic procedures have become safer by the reduced administration of suxamethonium and the use of total intravenous anaesthesia, new volatile anaesthetics and non-depolarising relaxants. This review provides a synopsis of pre-operative anaesthetic considerations and adverse drug effects on skeletal, cardiac and smooth muscle tissue. It describes the pathogenetic aspects of typical complications and introduces anaesthetic procedures for the various neuromuscular disorders, including regional anaesthesia for patients in whom a restriction of respiratory and/or cardiac function is predicted.
AB - The purpose of this review is to alert non-anaesthesiologists to the various complications from which patients with neuromuscular disorders and those susceptible to malignant hyperthermia can suffer during anaesthesia. The patient's outcome correlates with the quality of consultation between anaesthesiologists, surgeons, neurologists and cardiologists. Special precautions must be taken, since many anaesthetics and muscle relaxants can aggravate the clinical features or trigger life-threatening reactions. Complications frequently occur in these patients, although anaesthetic procedures have become safer by the reduced administration of suxamethonium and the use of total intravenous anaesthesia, new volatile anaesthetics and non-depolarising relaxants. This review provides a synopsis of pre-operative anaesthetic considerations and adverse drug effects on skeletal, cardiac and smooth muscle tissue. It describes the pathogenetic aspects of typical complications and introduces anaesthetic procedures for the various neuromuscular disorders, including regional anaesthesia for patients in whom a restriction of respiratory and/or cardiac function is predicted.
KW - Anaesthetics
KW - Cardiac complications
KW - Malignant hyperthermia
KW - Muscle relaxants
KW - Myotonia
KW - Neuromuscular disease
KW - Rhabdomyolysis
UR - http://www.scopus.com/inward/record.url?scp=13844297728&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2004.10.017
DO - 10.1016/j.nmd.2004.10.017
M3 - Review article
C2 - 15725581
AN - SCOPUS:13844297728
SN - 0960-8966
VL - 15
SP - 195
EP - 206
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 3
ER -